| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation elongation factor activity | 1.19e-05 | 20 | 45 | 3 | GO:0003746 | |
| GeneOntologyMolecularFunction | U6 snRNA binding | 7.43e-04 | 18 | 45 | 2 | GO:0017070 | |
| GeneOntologyMolecularFunction | translation factor activity, RNA binding | 9.28e-04 | 85 | 45 | 3 | GO:0008135 | |
| GeneOntologyMolecularFunction | fatty acid ligase activity | 1.56e-03 | 26 | 45 | 2 | GO:0015645 | |
| GeneOntologyMolecularFunction | CoA-ligase activity | 1.68e-03 | 27 | 45 | 2 | GO:0016405 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 2.05e-03 | 112 | 45 | 3 | GO:0090079 | |
| GeneOntologyMolecularFunction | acid-thiol ligase activity | 2.22e-03 | 31 | 45 | 2 | GO:0016878 | |
| GeneOntologyMolecularFunction | ribosome binding | 2.50e-03 | 120 | 45 | 3 | GO:0043022 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-sulfur bonds | 3.85e-03 | 41 | 45 | 2 | GO:0016877 | |
| GeneOntologyBiologicalProcess | positive regulation of translational termination | 3.88e-08 | 4 | 45 | 3 | GO:0045905 | |
| GeneOntologyBiologicalProcess | positive regulation of translational elongation | 9.67e-08 | 5 | 45 | 3 | GO:0045901 | |
| GeneOntologyBiologicalProcess | regulation of translational termination | 8.08e-07 | 9 | 45 | 3 | GO:0006449 | |
| GeneOntologyBiologicalProcess | positive regulation of protein-containing complex disassembly | 1.89e-06 | 41 | 45 | 4 | GO:0043243 | |
| GeneOntologyBiologicalProcess | regulation of translational elongation | 3.47e-06 | 14 | 45 | 3 | GO:0006448 | |
| GeneOntologyBiologicalProcess | translational termination | 6.46e-06 | 17 | 45 | 3 | GO:0006415 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 1.51e-05 | 144 | 45 | 5 | GO:0043244 | |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | 3.84e-05 | 291 | 45 | 6 | GO:0032984 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | 4.97e-05 | 617 | 45 | 8 | GO:0022411 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle cell apoptotic process | 2.35e-04 | 55 | 45 | 3 | GO:0010661 | |
| GeneOntologyBiologicalProcess | hematopoietic stem cell migration | 3.03e-04 | 12 | 45 | 2 | GO:0035701 | |
| Domain | IF5A_HYPUSINE | 1.22e-08 | 3 | 44 | 3 | PS00302 | |
| Domain | eIF-5a | 1.22e-08 | 3 | 44 | 3 | PF01287 | |
| Domain | Transl_elong_IF5A_C | 1.22e-08 | 3 | 44 | 3 | IPR020189 | |
| Domain | Trans_elong_IF5A_hypusine_site | 1.22e-08 | 3 | 44 | 3 | IPR019769 | |
| Domain | Transl_elong_IF5A | 1.22e-08 | 3 | 44 | 3 | IPR001884 | |
| Domain | eIF-5a | 1.22e-08 | 3 | 44 | 3 | SM01376 | |
| Domain | Translation_prot_SH3-like | 8.11e-06 | 17 | 44 | 3 | IPR008991 | |
| Domain | Rib_L2_dom2 | 9.71e-06 | 18 | 44 | 3 | IPR014722 | |
| Domain | - | 9.71e-06 | 18 | 44 | 3 | 2.30.30.30 | |
| Domain | KOW | 2.94e-04 | 11 | 44 | 2 | IPR005824 | |
| Domain | KOW | 2.94e-04 | 11 | 44 | 2 | PF00467 | |
| Domain | AMP-bd_C | 7.21e-04 | 17 | 44 | 2 | IPR025110 | |
| Domain | AMP-binding_C | 7.21e-04 | 17 | 44 | 2 | PF13193 | |
| Domain | NA-bd_OB-fold | 9.83e-04 | 83 | 44 | 3 | IPR012340 | |
| Domain | AMP-binding_CS | 1.70e-03 | 26 | 44 | 2 | IPR020845 | |
| Domain | AMP_BINDING | 1.97e-03 | 28 | 44 | 2 | PS00455 | |
| Domain | AMP-binding | 2.26e-03 | 30 | 44 | 2 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 2.26e-03 | 30 | 44 | 2 | IPR000873 | |
| Domain | ZINC_FINGER_C2H2_2 | 9.21e-03 | 775 | 44 | 6 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 9.32e-03 | 777 | 44 | 6 | PS00028 | |
| Domain | Znf_C2H2-like | 1.04e-02 | 796 | 44 | 6 | IPR015880 | |
| Domain | Znf_C2H2 | 1.10e-02 | 805 | 44 | 6 | IPR007087 | |
| Domain | ZnF_C2H2 | 1.12e-02 | 808 | 44 | 6 | SM00355 | |
| Pathway | REACTOME_HYPUSINE_SYNTHESIS_FROM_EIF5A_LYSINE | 2.27e-07 | 5 | 41 | 3 | MM14823 | |
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 11161802 | ||
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 36848144 | ||
| Pubmed | Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells. | 2.31e-09 | 3 | 47 | 3 | 16519677 | |
| Pubmed | Biological Relevance and Therapeutic Potential of the Hypusine Modification System. | 2.31e-08 | 5 | 47 | 3 | 26037925 | |
| Pubmed | Progenitor cell diversity in the developing mouse neocortex. | 6.55e-07 | 13 | 47 | 3 | 33649223 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 37047039 | ||
| Pubmed | Polyamines and eIF5A Hypusination Modulate Mitochondrial Respiration and Macrophage Activation. | 1.79e-06 | 2 | 47 | 2 | 31130465 | |
| Pubmed | Independent roles of eIF5A and polyamines in cell proliferation. | 1.79e-06 | 2 | 47 | 2 | 15377278 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 2492279 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 17707773 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 12894223 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 37653021 | ||
| Pubmed | Identification of a new member of the human eIF-5A gene family. | 1.79e-06 | 2 | 47 | 2 | 7622067 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 8253832 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 3095320 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 12393497 | ||
| Pubmed | Exosomal EIF5A derived from Lewis lung carcinoma induced adipocyte wasting in cancer cachexia. | 1.79e-06 | 2 | 47 | 2 | 37743008 | |
| Pubmed | Homology modelling of the human eukaryotic initiation factor 5A (eIF-5A). | 1.79e-06 | 2 | 47 | 2 | 11742107 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 20501948 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 37333770 | ||
| Pubmed | Acetyl-coenzyme A synthetase is a lipogenic enzyme controlled by SREBP-1 and energy status. | 5.36e-06 | 3 | 47 | 2 | 11739104 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 36893894 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 24891617 | ||
| Pubmed | ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies. | 5.36e-06 | 3 | 47 | 2 | 26788497 | |
| Pubmed | Essential role of eIF5A-1 and deoxyhypusine synthase in mouse embryonic development. | 5.36e-06 | 3 | 47 | 2 | 21850436 | |
| Pubmed | Klf5 down-regulation induces vascular senescence through eIF5a depletion and mitochondrial fission. | 5.36e-06 | 3 | 47 | 2 | 32817651 | |
| Pubmed | Identification and characterization of eukaryotic initiation factor 5A-2. | 5.36e-06 | 3 | 47 | 2 | 14622290 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 20181941 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 20458750 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 12210765 | ||
| Pubmed | A Dynamic Unfolded Protein Response Contributes to the Control of Cortical Neurogenesis. | 5.88e-06 | 26 | 47 | 3 | 26651292 | |
| Pubmed | Robo1 modulates proliferation and neurogenesis in the developing neocortex. | 6.61e-06 | 27 | 47 | 3 | 24741061 | |
| Pubmed | Zfhx3 is required for the differentiation of late born D1-type medium spiny neurons. | 8.25e-06 | 29 | 47 | 3 | 31491374 | |
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 9.63e-06 | 98 | 47 | 4 | 21942715 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 27399968 | ||
| Pubmed | BCL11B expression in intramembranous osteogenesis during murine craniofacial suture development. | 1.07e-05 | 4 | 47 | 2 | 25511173 | |
| Pubmed | The genomic structure encoding human initiation factor eIF-5A. | 1.07e-05 | 4 | 47 | 2 | 7545941 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 7759117 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 22927971 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 31558321 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 16452303 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 38019906 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 28507510 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 34688659 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 14630787 | ||
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 17631058 | ||
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 8107195 | ||
| Pubmed | 3.31e-05 | 272 | 47 | 5 | 31010829 | ||
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 26043730 | ||
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 23359715 | ||
| Pubmed | Expression pattern of Nav2 in the murine CNS with development. | 3.74e-05 | 7 | 47 | 2 | 32081718 | |
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 25978062 | ||
| Pubmed | Tubulin polyglutamylation stimulates spastin-mediated microtubule severing. | 4.98e-05 | 8 | 47 | 2 | 20530212 | |
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 34931379 | ||
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 23015591 | ||
| Pubmed | Upregulation of MicroRNA miR-9 Is Associated with Microcephaly and Zika Virus Infection in Mice. | 4.98e-05 | 8 | 47 | 2 | 30264295 | |
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 34188164 | ||
| Pubmed | 6.40e-05 | 9 | 47 | 2 | 36764294 | ||
| Pubmed | 6.40e-05 | 9 | 47 | 2 | 25972180 | ||
| Pubmed | 6.40e-05 | 9 | 47 | 2 | 33708771 | ||
| Pubmed | 6.40e-05 | 9 | 47 | 2 | 35135854 | ||
| Pubmed | 6.40e-05 | 9 | 47 | 2 | 31919899 | ||
| Pubmed | DISC1-dependent switch from progenitor proliferation to migration in the developing cortex. | 6.40e-05 | 9 | 47 | 2 | 21471969 | |
| Pubmed | 6.40e-05 | 9 | 47 | 2 | 38238293 | ||
| Pubmed | Essential role of PDZ-RGS3 in the maintenance of neural progenitor cells. | 6.40e-05 | 9 | 47 | 2 | 20629178 | |
| Pubmed | ATRX is required for maintenance of the neuroprogenitor cell pool in the embryonic mouse brain. | 6.40e-05 | 9 | 47 | 2 | 25395668 | |
| Pubmed | Cytoskeletal regulation by AUTS2 in neuronal migration and neuritogenesis. | 6.40e-05 | 9 | 47 | 2 | 25533347 | |
| Pubmed | KIF20A/MKLP2 regulates the division modes of neural progenitor cells during cortical development. | 6.40e-05 | 9 | 47 | 2 | 30006548 | |
| Pubmed | 6.40e-05 | 9 | 47 | 2 | 31319858 | ||
| Pubmed | Tcf4 is required for correct brain development during embryogenesis. | 6.40e-05 | 9 | 47 | 2 | 32474139 | |
| Pubmed | 6.40e-05 | 9 | 47 | 2 | 31541646 | ||
| Pubmed | 7.99e-05 | 10 | 47 | 2 | 39095712 | ||
| Pubmed | Exportin 4: a mediator of a novel nuclear export pathway in higher eukaryotes. | 7.99e-05 | 10 | 47 | 2 | 10944119 | |
| Pubmed | 7.99e-05 | 10 | 47 | 2 | 22069190 | ||
| Pubmed | 7.99e-05 | 10 | 47 | 2 | 25934499 | ||
| Pubmed | Mutations in SMARCB1 and in other Coffin-Siris syndrome genes lead to various brain midline defects. | 7.99e-05 | 10 | 47 | 2 | 31273213 | |
| Pubmed | Enhanced Abventricular Proliferation Compensates Cell Death in the Embryonic Cerebral Cortex. | 7.99e-05 | 10 | 47 | 2 | 27620979 | |
| Pubmed | 7.99e-05 | 10 | 47 | 2 | 27510895 | ||
| Pubmed | 7.99e-05 | 10 | 47 | 2 | 33790322 | ||
| Pubmed | The lysolipid transporter Mfsd2a regulates lipogenesis in the developing brain. | 7.99e-05 | 10 | 47 | 2 | 30074985 | |
| Pubmed | KCTD10 regulates brain development by destabilizing brain disorder-associated protein KCTD13. | 7.99e-05 | 10 | 47 | 2 | 38489388 | |
| Pubmed | FMRP regulates multipolar to bipolar transition affecting neuronal migration and cortical circuitry. | 7.99e-05 | 10 | 47 | 2 | 25402856 | |
| Pubmed | Glycine receptors control the generation of projection neurons in the developing cerebral cortex. | 7.99e-05 | 10 | 47 | 2 | 24926615 | |
| Pubmed | Notch Activation by Shootin1 Opposing Activities on 2 Ubiquitin Ligases. | 9.75e-05 | 11 | 47 | 2 | 28981589 | |
| Pubmed | The cerebrospinal fluid provides a proliferative niche for neural progenitor cells. | 9.75e-05 | 11 | 47 | 2 | 21382550 | |
| Pubmed | Gli3 is required for maintenance and fate specification of cortical progenitors. | 9.75e-05 | 11 | 47 | 2 | 21525285 | |
| Pubmed | A Human Pleiotropic Multiorgan Condition Caused by Deficient Wnt Secretion. | 9.75e-05 | 11 | 47 | 2 | 34587386 | |
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 21989910 | ||
| Pubmed | 7-Dehydrocholesterol-derived oxysterols cause neurogenic defects in Smith-Lemli-Opitz syndrome. | 9.75e-05 | 11 | 47 | 2 | 36111785 | |
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 32115408 | ||
| Pubmed | Tight junction protein occludin regulates progenitor Self-Renewal and survival in developing cortex. | 9.75e-05 | 11 | 47 | 2 | 31794381 | |
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 31816041 | ||
| Pubmed | FASN-dependent de novo lipogenesis is required for brain development. | 9.75e-05 | 11 | 47 | 2 | 34996870 | |
| Pubmed | Differential requirements of tubulin genes in mammalian forebrain development. | 9.75e-05 | 11 | 47 | 2 | 31386652 | |
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 34614421 | ||
| Pubmed | Oxidative stress regulates progenitor behavior and cortical neurogenesis. | 9.75e-05 | 11 | 47 | 2 | 32041791 | |
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 37172586 | ||
| Pubmed | Dual effect of CTCF loss on neuroprogenitor differentiation and survival. | 1.17e-04 | 12 | 47 | 2 | 24553927 | |
| Pubmed | 1.17e-04 | 12 | 47 | 2 | 27300315 | ||
| Pubmed | The KIF3 motor transports N-cadherin and organizes the developing neuroepithelium. | 1.17e-04 | 12 | 47 | 2 | 15834408 | |
| Cytoband | 5q14.1 | 7.42e-04 | 39 | 47 | 2 | 5q14.1 | |
| GeneFamily | Acyl-CoA synthetase family | 7.35e-04 | 26 | 28 | 2 | 40 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.48e-03 | 718 | 28 | 5 | 28 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.89e-05 | 150 | 47 | 4 | 2ba55e51877e2e749cccdae7df5d885dc55b2587 | |
| ToppCell | Healthy_donor-CD8+_T_naive|Healthy_donor / disease group, cell group and cell class (v2) | 3.02e-05 | 169 | 47 | 4 | 66216758e581365f10c2a66714d83a606ad23af0 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 3.54e-05 | 176 | 47 | 4 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 3.54e-05 | 176 | 47 | 4 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-CD8+_T_naive|COVID-19_Convalescent / Disease group, lineage and cell class | 4.21e-05 | 184 | 47 | 4 | 0299cd30a3ea8e861a9d529043c204048ae21d29 | |
| ToppCell | remission-CD8+_T_naive|remission / disease stage, cell group and cell class | 4.21e-05 | 184 | 47 | 4 | fe20fa4457d4a4a75689978275b0afb5f6243faf | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.30e-05 | 185 | 47 | 4 | 863a3d44c1f115942d7a2a2b63a92fe5fc768814 | |
| ToppCell | remission-CD8+_T_naive|World / disease stage, cell group and cell class | 4.30e-05 | 185 | 47 | 4 | 69304d7dd406ac7e96d51c239d7035a06d88704f | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.30e-05 | 185 | 47 | 4 | 27dbfcd40ec832d5cf757331d8af3b5176ae90fb | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 4.30e-05 | 185 | 47 | 4 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.30e-05 | 185 | 47 | 4 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | COVID-19_Convalescent-CD8+_T_naive|COVID-19_Convalescent / Disease condition and Cell class | 4.30e-05 | 185 | 47 | 4 | 2f8277a0b58fb0c49fa76ff6dfa6da961da1f9f5 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 4.30e-05 | 185 | 47 | 4 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.30e-05 | 185 | 47 | 4 | 1c23891e4d75f99296d1304af7a9d6c3cb28d04c | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.30e-05 | 185 | 47 | 4 | ca8e921a6b45cd39474b9f86c95e7be023585c5d | |
| ToppCell | Control-Lymphocyte-T_NK-CD8_Naive|Control / Disease, Lineage and Cell Type | 4.48e-05 | 187 | 47 | 4 | cf8bebef36e1ec76a22f229e5c073b3a201d1b93 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.48e-05 | 187 | 47 | 4 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.48e-05 | 187 | 47 | 4 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.48e-05 | 187 | 47 | 4 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | mild_COVID-19-CD8+_T_naive|mild_COVID-19 / disease group, cell group and cell class (v2) | 4.58e-05 | 188 | 47 | 4 | 60d27014e5f9e562efe2a602482ea1d07efd0331 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 4.58e-05 | 188 | 47 | 4 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | mild_COVID-19-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 4.58e-05 | 188 | 47 | 4 | ddfb1c64305825fb0bc23819aa001bfc2ac4c2b2 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.67e-05 | 189 | 47 | 4 | c121817ddad164e9cfe382c43d0cbc9215508d02 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.77e-05 | 190 | 47 | 4 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.77e-05 | 190 | 47 | 4 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.87e-05 | 191 | 47 | 4 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.87e-05 | 191 | 47 | 4 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.87e-05 | 191 | 47 | 4 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.97e-05 | 192 | 47 | 4 | ad2e0f35d50fe4e6977eba8a7a2bd990f6946305 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.97e-05 | 192 | 47 | 4 | c3dda7c48732b0b8bde36de282d64192f5e9b98f | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.97e-05 | 192 | 47 | 4 | 284955fec5103194d416320f41fa4d87c7efc4fb | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.97e-05 | 192 | 47 | 4 | 0d3b2b9cd586a4adbc3755563dd50b140227c287 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.97e-05 | 192 | 47 | 4 | 67f50e5b1d449923002dc5b5d0c4d32c523034d3 | |
| ToppCell | Control-CD8+_T_naive|Control / Disease condition and Cell class | 5.07e-05 | 193 | 47 | 4 | 627d345baf1940218c61907305705298e473dbab | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 5.07e-05 | 193 | 47 | 4 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-CD8_Naive|Multiple_Sclerosis / Disease, Lineage and Cell Type | 5.17e-05 | 194 | 47 | 4 | 42a9a170022f07445a7ee2577707924bbc0269db | |
| ToppCell | IPF-Endothelial|IPF / Disease state, Lineage and Cell class | 5.17e-05 | 194 | 47 | 4 | 9591993aa2dcba3d09a0f1ea8b8f2439c26482d6 | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 5.17e-05 | 194 | 47 | 4 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 5.27e-05 | 195 | 47 | 4 | 120296531bbc8080dcabacbd64733cc1dc34603a | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|IPF / Disease state, Lineage and Cell class | 5.27e-05 | 195 | 47 | 4 | 2c3ad3cb79f11119ac69c413a938d21199145040 | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.27e-05 | 195 | 47 | 4 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.49e-05 | 197 | 47 | 4 | 0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780 | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.49e-05 | 197 | 47 | 4 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | (221)_CD8+_Naive_T_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 5.49e-05 | 197 | 47 | 4 | 59621a1f016b9f467e69bd5977ccdafa03b4ce21 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.49e-05 | 197 | 47 | 4 | 2430f31d9312338e0ca23bfc6bdb0365340860fd | |
| ToppCell | IIF-Lymphocyte-T_NK-CD8_Naive|IIF / Disease, Lineage and Cell Type | 5.49e-05 | 197 | 47 | 4 | fa376bde80ed0ae57ae064ff7165cfb870724b93 | |
| ToppCell | mild|World / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.60e-05 | 198 | 47 | 4 | 3cef2e13d5ec71bb265171239980697a2560fa30 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T8_naive|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.71e-05 | 199 | 47 | 4 | 40eb207fa0f07e2e4d0be69530b8f61f7ea49c73 | |
| ToppCell | Parenchymal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.71e-05 | 199 | 47 | 4 | a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T8_naive-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.71e-05 | 199 | 47 | 4 | 67b9ff07de5be0895612c201cb21e66a3f88669a | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T8_naive|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.71e-05 | 199 | 47 | 4 | e47f8314a4822bf00d0999316457f95c338585e1 | |
| ToppCell | control-CD8+_T_naive|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.71e-05 | 199 | 47 | 4 | 6a61ce7404c65e506091fee99a2001f5a9b39f31 | |
| ToppCell | severe-CD8+_T_naive|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.71e-05 | 199 | 47 | 4 | 656e639228b3f2dca6955a487e4999e73a69bc51 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T8_naive-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.71e-05 | 199 | 47 | 4 | 6ed413872301707dc73ae66365bee94cd38a292c | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-CD8+_T_naive|Multiple_Sclerosis / Disease, condition lineage and cell class | 5.82e-05 | 200 | 47 | 4 | 3c919578aed30f77408a3405bce7b71bcda203e0 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD8+_T_naive|COVID-19_Mild / Disease, condition lineage and cell class | 5.82e-05 | 200 | 47 | 4 | 7192138e2704c030d70561bcd59259fb3ad82f06 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-CD8+_T_naive|IIF / Disease, condition lineage and cell class | 5.82e-05 | 200 | 47 | 4 | 350b189d0baca9516375786c3712c76c6b4fb390 | |
| ToppCell | mild-CD8+_T_naive|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.82e-05 | 200 | 47 | 4 | c2513047ef110a64c89a624e299cb9600a9cb92c | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-CD8+_T_naive|COVID-19_Convalescent / Disease, condition lineage and cell class | 5.82e-05 | 200 | 47 | 4 | 65ae349fac4084faacbc6a645a92398f6324770e | |
| ToppCell | COVID-19_Mild-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 3.03e-04 | 124 | 47 | 3 | 5ef9eb806fb2c8ee5aae0a75503d244b08ee10d4 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.18e-04 | 126 | 47 | 3 | 69b2525b92d1c7c35b21cc701f5fa52a9c1b94bb | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.18e-04 | 126 | 47 | 3 | 6cb89754010d64875e115da6c5805efac7a4a82d | |
| ToppCell | Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.48e-04 | 130 | 47 | 3 | ab141d91988a5de6d092757377a53f7de3707556 | |
| ToppCell | Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.48e-04 | 130 | 47 | 3 | 3d81151ee1369d819843826fc6ac197d83255e1d | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-6|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 3.64e-04 | 132 | 47 | 3 | b7611c6a5c86908132e7ab3e41d67277e8142db1 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Follicular-6|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 3.89e-04 | 135 | 47 | 3 | 8197d49e697a1fdcd64040ea7a7f0b3ad0a756eb | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|blood / Manually curated celltypes from each tissue | 3.97e-04 | 136 | 47 | 3 | f024015bf60e64b8657e410e24995a1edec85196 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-04 | 138 | 47 | 3 | 19ffd66256fa94d728138d37d0a5a3bac7722dbb | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-04 | 138 | 47 | 3 | 321070b6900887b27da0f2b25808a05a8ab89ee7 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.24e-04 | 139 | 47 | 3 | ecc2a6ecc27748c50885cd4f0ad8a8cd1252aee6 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.33e-04 | 140 | 47 | 3 | 0e1e9281de87df178ac41ed6b697b4fa09be2749 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.70e-04 | 144 | 47 | 3 | ea174487f8ade90deb33b964a7f7e65062606565 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-04 | 144 | 47 | 3 | 1d05aa08603cba28c0c6511767e434c1f592a3aa | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-04 | 144 | 47 | 3 | d3f6f5da56794367ee3776bfd3a9dcf893efe0f0 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Cpne7|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.19e-04 | 149 | 47 | 3 | 8638b3819193d11411df58964069fec583f617f4 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.29e-04 | 150 | 47 | 3 | 4f31867cb85253ff6d22f3b02ef972a42cb41123 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-8|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.29e-04 | 150 | 47 | 3 | 1aa9320d97ff10994ea024751790524fe133aba9 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.50e-04 | 152 | 47 | 3 | b6a7453fbf9f898e4f222b215907c9a110baa2f6 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.60e-04 | 153 | 47 | 3 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.60e-04 | 153 | 47 | 3 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-04 | 154 | 47 | 3 | a5289000597068ee8d559f89bce7bce31f35dd57 | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.82e-04 | 155 | 47 | 3 | 08295584395e8d9cfc1b1648f98754b3ac53e587 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.82e-04 | 155 | 47 | 3 | 969fc4c98a96bf2f436e8e63d4deb2183ef3b864 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.93e-04 | 156 | 47 | 3 | fe383ce3a0c37f7343d7026cb51260a04d4c2829 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.04e-04 | 157 | 47 | 3 | 275a4c6fef1fff8da2bdc48e3924ad05c5e5cfc8 | |
| ToppCell | Control-Endothelial-Epi-like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.04e-04 | 157 | 47 | 3 | 4d02c50d5d1b892ea241e98724386d8a5a156a46 | |
| ToppCell | Control-Endothelial-Epi-like-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.04e-04 | 157 | 47 | 3 | 2c369660c752c0fb3bd798a561d3359e2f9aa983 | |
| ToppCell | Healthy/Control-CD8+_T_naive|Healthy/Control / Disease group and Cell class | 6.38e-04 | 160 | 47 | 3 | e1386c21fcbbf57fa32d8bdfba3cb1887477ff73 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.38e-04 | 160 | 47 | 3 | 778faada072e3abfa76a9a06fd4885fb63de7902 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D122|Adult / Lineage, Cell type, age group and donor | 6.38e-04 | 160 | 47 | 3 | 0cfe130606af433b2aa90e0a20b6c44659dd6fd4 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.50e-04 | 161 | 47 | 3 | 1f4614ae15bd2fc08e555cea4d0152c4a940d048 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 6.50e-04 | 161 | 47 | 3 | 537a1d86de99a493b0345ca0f760994260e97049 | |
| ToppCell | Healthy_donor-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 6.50e-04 | 161 | 47 | 3 | 8a61395af33132783a0a37956c6f821aba5d3b1e | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.61e-04 | 162 | 47 | 3 | 58da6bc04cdac0002b0e6a751c96ff95e1a7f70f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.61e-04 | 162 | 47 | 3 | 4d13c271b4f63cf32980e5643b5d5951165fe8b5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_RSAD2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.85e-04 | 164 | 47 | 3 | 1ddfa222732ecfa0fbc359fb342a9fed8bd86272 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.85e-04 | 164 | 47 | 3 | 90afae3cca108ebfb44ff2ec4adcbb8c68a0bdf2 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.98e-04 | 165 | 47 | 3 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.98e-04 | 165 | 47 | 3 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.98e-04 | 165 | 47 | 3 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| Disease | Self-injurious behavior | 2.18e-04 | 78 | 44 | 3 | HP_0100716 | |
| Disease | kidney disease (biomarker_via_orthology) | 4.48e-04 | 21 | 44 | 2 | DOID:557 (biomarker_via_orthology) | |
| Disease | selenium measurement | 8.60e-04 | 29 | 44 | 2 | EFO_0006331 | |
| Disease | QT interval | 1.16e-03 | 534 | 44 | 5 | EFO_0004682 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 1.89e-03 | 43 | 44 | 2 | DOID:2476 (implicated_via_orthology) | |
| Disease | reading and spelling ability | 1.96e-03 | 166 | 44 | 3 | EFO_0005301 | |
| Disease | calcium measurement | 2.35e-03 | 628 | 44 | 5 | EFO_0004838 | |
| Disease | IGFBP-3 measurement | 2.96e-03 | 54 | 44 | 2 | EFO_0004626 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EKHGSWGSGLDMHTK | 326 | Q93088 | |
| KGGVDHTKMSLHGAS | 41 | Q9BSF8 | |
| FSKMKTSRHSSGGGG | 181 | P55198 | |
| HVTGSGASAGTHKRM | 431 | P55198 | |
| SHVIGIKGDKGSMGH | 1261 | Q01955 | |
| MKGLSGSRSHHHGVT | 1 | O14490 | |
| KNGSVMSHLGASTHG | 51 | Q9H0Y0 | |
| KHLGRAELGMGDSTS | 251 | Q9NR19 | |
| KQDMSKSNGKRHHGT | 986 | Q9NSY1 | |
| MGGGVSEGRSHSKRK | 1046 | Q8TDY8 | |
| TLKKELGRNGGSMHH | 981 | P49796 | |
| IKVKNHSGGGMSLTH | 451 | Q5JSJ4 | |
| QTSSGKTHTMEGKLH | 86 | P33176 | |
| GTNRHGMKAAKHGSE | 211 | Q9NQU5 | |
| VEMSTSKTGKHGHAK | 41 | Q9GZV4 | |
| VGHLMGKKSTGESSS | 46 | P07492 | |
| TVDHLKMLHATGGTG | 91 | Q9NQ87 | |
| VEMSTSKTGKHGHAK | 41 | P63241 | |
| HTHTEPTGDGKSMKA | 1661 | P46013 | |
| KGRHKAFGTCSSHLM | 236 | Q5JQS5 | |
| VEMSASKTGKHGHAK | 41 | Q6IS14 | |
| SSKLTRHMKTHGQIG | 836 | Q9C0K0 | |
| KGSTSEKDGMHHTVT | 951 | O14981 | |
| KQDMSKSNGKRHHGT | 236 | Q5H9B9 | |
| GAGADTLKTLGSHMS | 251 | Q9UJQ4 | |
| GLSNMGSHTGKELDK | 71 | Q6UWP8 | |
| AEGSKKSLSSEGHHM | 836 | Q8IZU8 | |
| STGHGRGHESSMKKL | 21 | Q9NNZ6 | |
| SSHGHVMSTGLLEAK | 616 | Q8NAN2 | |
| GHVRRHMNKGETKSS | 201 | Q7Z2T5 | |
| HTGHLTIAGCKMSKS | 396 | P49589 | |
| HTTGGLGDHAMSKKR | 91 | O43897 | |
| ELSSQTGGGMHKKDT | 421 | Q8NI08 | |
| GKLMELHGEGSSSGK | 226 | P61247 | |
| TVMKTGSAGLSGHHR | 251 | Q9UBP0 | |
| KTALMKGEDGGHSLS | 3231 | Q9NRC6 | |
| TMGKHTGGHLTATNL | 681 | P36956 | |
| TSGTTGFPKMAKHSH | 226 | Q08AH1 | |
| MGRHSQSRSHSKGKS | 326 | B3KS81 | |
| KIHGTFHMQKTGNGS | 1036 | Q96K83 | |
| DKAMGKLGTSLSSGH | 641 | P80108 | |
| GEMKKGLGSLSHGRT | 391 | O94885 | |
| HRFHGKGSGKMKTER | 731 | O43290 | |
| KKSHGRSLMTNFGKH | 541 | Q4KWH8 | |
| ESLKHGCGKHFRMSS | 411 | P59923 | |
| KIHGTFHMQKLAGSS | 1036 | Q2M1K9 | |
| GSRGAMDTKGHKTAG | 696 | Q05996 | |
| RAKHRKEGSHGLSML | 5761 | P20929 |